These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 37280636)

  • 1. Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer's Disease drug candidate.
    Nemergut M; Marques SM; Uhrik L; Vanova T; Nezvedova M; Gadara DC; Jha D; Tulis J; Novakova V; Planas-Iglesias J; Kunka A; Legrand A; Hribkova H; Pospisilova V; Sedmik J; Raska J; Prokop Z; Damborsky J; Bohaciakova D; Spacil Z; Hernychova L; Bednar D; Marek M
    Mol Neurodegener; 2023 Jun; 18(1):38. PubMed ID: 37280636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
    Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
    CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids.
    Zhao J; Fu Y; Yamazaki Y; Ren Y; Davis MD; Liu CC; Lu W; Wang X; Chen K; Cherukuri Y; Jia L; Martens YA; Job L; Shue F; Nguyen TT; Younkin SG; Graff-Radford NR; Wszolek ZK; Brafman DA; Asmann YW; Ertekin-Taner N; Kanekiyo T; Bu G
    Nat Commun; 2020 Nov; 11(1):5540. PubMed ID: 33139712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
    J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Assessment of Conformational Heterogeneity in Apolipoprotein E4 Using Hydrogen-Deuterium Exchange Mass Spectrometry.
    Dolai S; Pal S; Deepa S; Garai K
    J Phys Chem B; 2024 Oct; 128(41):10075-10085. PubMed ID: 39360975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E.
    Ray A; Ahalawat N; Mondal J
    Biophys J; 2017 Dec; 113(12):2682-2694. PubMed ID: 29262361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of apolipoprotein E3/E4 heteromerization.
    Tu KH; Abhari D; Narayanaswami V
    FEBS J; 2019 May; 286(10):1986-1998. PubMed ID: 30802357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry.
    Chetty PS; Mayne L; Lund-Katz S; Englander SW; Phillips MC
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):968-973. PubMed ID: 28096372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.
    Rawat V; Wang S; Sima J; Bar R; Liraz O; Gundimeda U; Parekh T; Chan J; Johansson JO; Tang C; Chui HC; Harrington MG; Michaelson DM; Yassine HN
    J Neurosci; 2019 Nov; 39(48):9611-9622. PubMed ID: 31641056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential.
    Abushakra S; Porsteinsson A; Scheltens P; Sadowsky C; Vellas B; Cummings J; Gauthier S; Hey JA; Power A; Wang P; Shen L; Tolar M
    J Prev Alzheimers Dis; 2017; 4(3):149-156. PubMed ID: 29182706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease.
    Frieden C; Garai K
    Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8913-8. PubMed ID: 22615372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
    Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist.
    Litvinchuk A; Suh JH; Guo JL; Lin K; Davis SS; Bien-Ly N; Tycksen E; Tabor GT; Remolina Serrano J; Manis M; Bao X; Lee C; Bosch M; Perez EJ; Yuede CM; Cashikar AG; Ulrich JD; Di Paolo G; Holtzman DM
    Neuron; 2024 Feb; 112(3):384-403.e8. PubMed ID: 37995685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
    Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
    Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo.
    Dieckmann M; Beil FT; Mueller B; Bartelt A; Marshall RP; Koehne T; Amling M; Ruether W; Cooper JA; Humphries SE; Herz J; Niemeier A
    J Bone Miner Res; 2013 Feb; 28(2):236-45. PubMed ID: 22991192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides.
    Simon R; Girod M; Fonbonne C; Salvador A; Clément Y; Lantéri P; Amouyel P; Lambert JC; Lemoine J
    Mol Cell Proteomics; 2012 Nov; 11(11):1389-403. PubMed ID: 22918225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.